CytomX Therapeutics shares yo-yoed this past week, surging on positive early clinical data for its colorectal cancer candidate, then retreating on investor questions about the data. Also, Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results